Treatment with the PPARα agonist fenofibrate improves the efficacy of CD8+ T cell therapy for melanoma
Mohadeseh Hasanpourghadi, Arezki Chekaoui, Sophia Kurian, Raj K. Kurupati, Robert Ambrose, Wynetta Giles‐Davis, Amara Saha, Xiaowei Xu, Hildegund C.J. Ertl
Abstract
expanded TILs.
Topics & Concepts
FenofibrateAgonistMedicineMelanomaCD8Internal medicineOncologyCancer researchReceptorImmunologyImmune systemCAR-T cell therapy researchCancer Immunotherapy and BiomarkersMelanoma and MAPK Pathways